StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
48
This year
9
Publishing Date
2024 - 03 - 22
1
2024 - 03 - 11
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 02
1
2024 - 01 - 30
1
2024 - 01 - 29
2
2024 - 01 - 17
1
2023 - 12 - 04
1
2023 - 10 - 20
1
2023 - 10 - 11
1
2023 - 10 - 03
1
2023 - 08 - 15
1
2023 - 07 - 27
1
2023 - 07 - 14
1
2023 - 06 - 28
1
2023 - 05 - 03
1
2023 - 04 - 14
2
2023 - 04 - 11
1
2023 - 03 - 20
1
2023 - 03 - 10
1
2023 - 01 - 09
1
2023 - 01 - 03
1
2022 - 12 - 08
1
2022 - 10 - 14
1
2022 - 10 - 05
1
2022 - 10 - 04
2
2022 - 09 - 28
1
2022 - 09 - 20
1
2022 - 09 - 05
1
2022 - 08 - 05
1
2022 - 06 - 24
1
2022 - 06 - 20
1
2022 - 05 - 02
1
2022 - 04 - 25
1
2022 - 04 - 12
1
2022 - 03 - 14
1
2022 - 03 - 07
1
2022 - 02 - 22
1
2022 - 02 - 18
1
2021 - 12 - 16
1
2021 - 11 - 02
1
2021 - 10 - 27
1
2021 - 10 - 13
1
2021 - 10 - 08
1
Sector
Consumer non-durables
1
Health technology
48
Manufacturing
48
N/a
15
Producer manufacturing
1
Tags
Abbvie
1
Acne
1
Acute myeloid leukemia
1
America
3
Aml
1
Anemia
1
Antibiotics
1
Asia
1
Astrazeneca
1
Biotech
2
Cancer
2
Cell
1
Companies
1
Dermatitis
1
Device
1
Diagnostic
1
Diagnostics
1
Disease
3
Drug
5
Earnings
1
Ema
1
Europe
1
Expansion
1
Expected
3
Funding
1
Global
8
Growing
2
Growth
18
Heart
1
Infections
1
Key
2
Kidney
1
Leukemia
2
Liver
1
Lung
3
Market
37
Million
2
Myeloid leukemia
1
N/a
47
Nervous system
1
Order
2
Pharma
5
Plus
1
Pneumococcal
1
Potential
1
Psoriasis
1
Rare
1
Reach
1
Renal
2
Report
7
Research
5
Results
1
Stem cell
1
System
1
Therapeutics
10
Therapy
1
Treatment
7
Trends
1
Vaccine
6
Entities
3m company
14
Abbott laboratories
128
Abbvie inc.
155
Adaptimmune therapeutics plc
6
Agenus inc.
7
Albemarle corporation
6
Alector, inc.
4
Alkermes plc
9
Alphabet inc.
5
Amgen inc.
110
Aptargroup, inc.
7
Arrowhead pharmaceuticals, inc.
5
Astellas pharma inc
48
Astrazeneca plc
189
Bausch health companies inc.
39
Baxter international inc.
31
Becton, dickinson and company
11
Biogen inc.
24
Biomarin pharmaceutical inc.
6
Biontech se
13
Boston scientific corporation
9
Bristol-myers squibb company
67
Csl ltd
23
Curevac n.v.
44
Eli lilly and company
106
Endo international plc
19
General electric company
6
Genmab a/s
7
Gilead sciences, inc.
24
Glaxosmithkline plc
883
Grifols sa
5
Herbalife nutrition ltd.
5
Incyte corporation
7
Insulet corporation
6
Jazz pharmaceuticals plc
11
Johnson & johnson
191
Kellogg company
5
Koninklijke philips n.v.
17
Koninklijke philips nv
5
Mallinckrodt plc
10
Medies
6
Medtronic plc
22
Mitsubishi chemical holdings corp
7
Moderna, inc.
7
Novartis ag
304
Novo nordisk a/s
26
Orange
7
Perrigo company
15
Pfizer, inc.
64
Prestige consumer healthcare inc.
6
Puma biotechnology inc
5
Reckitt benckiser group plc
21
Sanofi
334
Takeda pharmaceutical company limited
34
Teva pharmaceutical industries limited
14
Teva pharmaceutical industries ltd
147
Thermo fisher scientific inc
13
Unilever plc
7
Viatris inc.
78
Vir biotechnology, inc.
23
Symbols
ABBV
49
ABEO
7
ABT
21
ADAP
7
ADXS
2
AFMD
2
ALNY
2
ALPMF
332
ALPMY
332
AMGN
31
APVO
2
AZN
42
AZNCF
42
BAX
4
BCLI
5
BHC
6
BIIB
11
BMY
11
BNTX
5
CLYYF
4
CMXHF
12
CSLLY
12
ENDP
4
ENDPQ
3
EPIX
4
FGEN
3
FNCTF
3
GBIO
6
GILD
3
GLAXF
48
GSK
48
INCY
6
IONS
3
ISEE
10
JAZZ
4
JNJ
26
LLY
25
MDT
3
MEOBF
6
MNK
7
MNKKQ
6
MNKPF
4
MRK
4
MTLHF
3
MTLHY
3
NVO
3
NVS
70
NVSEF
70
ORTX
7
PFE
26
SGEN
20
SNY
70
SNYNF
70
TAK
12
TEVJF
27
TMO
4
TWST
3
UCBJF
4
UCBJY
4
VTRS
22
Exchanges
Nasdaq
48
Nyse
48
Crawled Date
2024 - 03 - 22
1
2024 - 03 - 11
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 02
1
2024 - 01 - 30
2
2024 - 01 - 29
1
2024 - 01 - 17
1
2023 - 12 - 04
1
2023 - 10 - 20
1
2023 - 10 - 11
1
2023 - 10 - 03
1
2023 - 08 - 15
1
2023 - 07 - 27
1
2023 - 07 - 14
1
2023 - 06 - 28
1
2023 - 05 - 03
1
2023 - 04 - 14
2
2023 - 04 - 11
1
2023 - 03 - 20
1
2023 - 03 - 10
1
2023 - 01 - 09
1
2023 - 01 - 03
1
2022 - 12 - 08
1
2022 - 10 - 14
1
2022 - 10 - 05
1
2022 - 10 - 04
2
2022 - 09 - 28
1
2022 - 09 - 20
1
2022 - 09 - 05
1
2022 - 08 - 05
1
2022 - 06 - 24
1
2022 - 06 - 20
1
2022 - 05 - 02
1
2022 - 04 - 25
1
2022 - 04 - 12
1
2022 - 03 - 14
1
2022 - 03 - 07
1
2022 - 02 - 22
1
2022 - 02 - 18
1
2021 - 12 - 16
1
2021 - 11 - 02
1
2021 - 10 - 27
1
2021 - 10 - 13
1
2021 - 10 - 08
1
Crawled Time
00:00
1
01:00
2
02:00
1
03:00
1
04:00
3
05:00
3
06:00
2
07:00
1
08:00
1
09:00
3
10:00
1
11:00
4
12:00
1
13:00
2
13:30
1
14:00
1
14:30
1
15:20
1
15:30
1
16:00
4
18:00
2
19:00
6
20:00
1
21:00
1
23:00
3
Source
www.biospace.com
1
www.prnewswire.com
47
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Astellas pharma inc
symbols :
GSK
save search
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published:
2024-03-22
(Crawled : 04:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-13.49%
|
O:
-0.54%
H:
0.0%
C:
0.0%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-1.71%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.29%
|
O:
2.67%
H:
0.0%
C:
-1.58%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-15.63%
|
O:
2.26%
H:
0.0%
C:
-2.65%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-6.54%
|
O:
0.4%
H:
0.33%
C:
-0.45%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-6.49%
|
O:
0.16%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
3.13%
|
O:
0.45%
H:
0.53%
C:
-0.35%
market
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published:
2024-03-11
(Crawled : 14:30)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-5.41%
|
O:
0.41%
H:
0.0%
C:
0.0%
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-6.8%
|
O:
-4.92%
H:
3.76%
C:
3.44%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-5.92%
|
O:
-3.4%
H:
1.49%
C:
1.49%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.19%
|
O:
1.55%
H:
0.82%
C:
0.16%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-12.05%
|
O:
-1.41%
H:
5.06%
C:
4.01%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-8.21%
|
O:
-0.6%
H:
0.19%
C:
0.09%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-11.91%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-5.31%
|
O:
0.57%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
2.65%
|
O:
1.08%
H:
0.82%
C:
0.67%
pharma
vaccine
astrazeneca
research
key
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
25.87%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.24%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-5.58%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-5.13%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-6.33%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-3.44%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-6.54%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-7.44%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
News
|
$14.2
3.5%
3.38%
690K
|
Health Technology
|
-25.59%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$393.51
0.1%
0.1%
950K
|
Health Technology
|
-5.63%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.4
-0.42%
-0.42%
11K
|
Health Technology
|
-8.91%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.82
0.19%
0.19%
1.8M
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$358.65
-2.06%
-2.11%
240K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-10.02%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Heart Transplantation Therapeutics Market Projected for USD 135.37 Million Growth between 2024 and 2028: Market to Focus on Newer Techniques for Heart Transplantation - Technavio
Published:
2024-02-02
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-20.39%
|
O:
-3.89%
H:
0.0%
C:
0.0%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
1.0%
|
O:
-0.7%
H:
0.0%
C:
0.0%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-19.13%
|
O:
-4.76%
H:
7.0%
C:
3.18%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-2.54%
|
O:
-0.05%
H:
0.59%
C:
0.27%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
0.95%
|
O:
3.59%
H:
0.0%
C:
0.0%
million
heart
therapeutics
growth
market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published:
2024-01-30
(Crawled : 23:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-16.94%
|
O:
4.34%
H:
0.0%
C:
0.0%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
4.69%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.09%
|
O:
3.41%
H:
0.0%
C:
-2.45%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-19.27%
|
O:
0.0%
H:
1.38%
C:
0.26%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-5.84%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-13.61%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
1.3%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
0.15%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-9.47%
|
O:
1.75%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
1.58%
|
O:
0.82%
H:
0.12%
C:
-1.64%
market
Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published:
2024-01-29
(Crawled : 00:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-11.05%
|
O:
-1.84%
H:
0.52%
C:
0.52%
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-9.68%
|
O:
-0.25%
H:
1.0%
C:
0.98%
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-15.47%
|
O:
1.76%
H:
0.0%
C:
0.0%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
6.51%
|
O:
2.93%
H:
0.0%
C:
-1.15%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
2.13%
|
O:
3.1%
H:
0.0%
C:
-3.91%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-19.48%
|
O:
-3.53%
H:
3.49%
C:
3.4%
TVTX
|
$5.805
-3.09%
-3.19%
970K
|
Health Technology
|
-35.73%
|
O:
-1.39%
H:
0.16%
C:
-1.96%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
1.38%
|
O:
0.26%
H:
0.13%
C:
-0.18%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
1.6%
|
O:
0.24%
H:
0.01%
C:
-0.22%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-15.48%
|
O:
-0.29%
H:
0.76%
C:
0.67%
companies
renal
anemia
key
therapeutics
growth
market
Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published:
2024-01-29
(Crawled : 18:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-15.47%
|
O:
1.76%
H:
0.0%
C:
0.0%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
6.51%
|
O:
2.93%
H:
0.0%
C:
-1.15%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-19.48%
|
O:
-3.53%
H:
3.49%
C:
3.4%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-13.77%
|
O:
-0.59%
H:
0.49%
C:
0.41%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
1.38%
|
O:
0.26%
H:
0.13%
C:
-0.18%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
0.76%
|
O:
0.19%
H:
0.46%
C:
0.43%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-9.36%
|
O:
0.12%
H:
0.0%
C:
0.0%
kidney
renal
expected
million
therapeutics
growth
market
Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio
Published:
2024-01-17
(Crawled : 06:00)
- prnewswire.com
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-6.21%
|
O:
-0.64%
H:
0.54%
C:
0.54%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
3.11%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-22.81%
|
O:
-1.74%
H:
0.0%
C:
-1.35%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-13.57%
|
O:
0.49%
H:
0.18%
C:
0.04%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-0.7%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
1.95%
|
O:
-0.15%
H:
0.74%
C:
0.18%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-11.92%
|
O:
0.45%
H:
0.06%
C:
-0.5%
america
therapeutics
market
Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published:
2023-12-04
(Crawled : 18:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-18.56%
|
O:
0.26%
H:
0.0%
C:
0.0%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
9.78%
|
O:
-2.6%
H:
1.1%
C:
-1.18%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-1.28%
|
O:
0.27%
H:
0.12%
C:
0.12%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.4%
|
O:
-1.1%
H:
0.0%
C:
0.0%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-22.81%
|
O:
0.0%
H:
0.5%
C:
0.17%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.97%
|
O:
-1.86%
H:
0.34%
C:
-0.19%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
8.11%
|
O:
-1.01%
H:
0.39%
C:
0.19%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
15.19%
|
O:
0.51%
H:
0.68%
C:
0.32%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-2.73%
|
O:
-0.5%
H:
0.0%
C:
0.0%
GLMD
|
$0.3669
-0.41%
-0.41%
27K
|
Health Technology
|
-5.1%
|
O:
0.03%
H:
2.44%
C:
-1.03%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-2.79%
|
O:
-0.25%
H:
0.05%
C:
-0.37%
america
market
Global Acute Myeloid Leukemia (AML) Treatment Market Trends Analysis Report 2023-2028 - Personalized Medicine and Patient Advocacy Drive Opportunities
Published:
2023-10-20
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-26.37%
|
O:
-4.45%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-14.38%
|
O:
-3.95%
H:
0.0%
C:
-0.72%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-25.1%
|
O:
-2.89%
H:
3.67%
C:
2.85%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
11.9%
|
O:
0.42%
H:
0.54%
C:
0.11%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-13.22%
|
O:
-0.17%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-5.58%
|
O:
0.0%
H:
0.16%
C:
-0.64%
report
treatment
global
trends
leukemia
market
Topical Corticosteroids Market to grow by USD 1.09 billion from 2022-2027, Asia to account for 31% of market growth - Technavio
Published:
2023-10-11
(Crawled : 05:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
8.05%
|
O:
-1.75%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
0.69%
|
O:
0.07%
H:
0.0%
C:
-0.38%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.77%
|
O:
0.03%
H:
0.0%
C:
-0.23%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-32.15%
|
O:
-3.81%
H:
5.97%
C:
2.57%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
15.59%
|
O:
0.0%
H:
1.3%
C:
0.73%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.47%
|
O:
1.03%
H:
0.03%
C:
-0.07%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
6.05%
|
O:
0.72%
H:
0.24%
C:
-0.13%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
10.56%
|
O:
-0.08%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-16.1%
|
O:
1.1%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
0.37%
|
O:
-0.31%
H:
0.34%
C:
0.31%
asia
growth
market
Penicillin Market size is to grow by USD 2.45 billion from 2022 to 2027, North America to account for 31% of market growth - Technavio
Published:
2023-10-03
(Crawled : 03:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-31.28%
|
O:
-2.94%
H:
0.0%
C:
-0.07%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-32.37%
|
O:
-2.1%
H:
0.15%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
10.65%
|
O:
-1.29%
H:
0.1%
C:
-2.72%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-8.33%
|
O:
-1.6%
H:
0.36%
C:
-0.46%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
9.73%
|
O:
0.25%
H:
0.08%
C:
-0.8%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
11.73%
|
O:
0.57%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-15.82%
|
O:
-1.41%
H:
0.0%
C:
0.0%
america
growth
market
Onychomycosis Treatment Market size to grow by USD 1,776.53 million from 2022 to 2027; Growth driven by increasing prevalence of onychomycosis - Technavio
Published:
2023-08-15
(Crawled : 05:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-12.75%
|
O:
-2.02%
H:
0.0%
C:
-1.05%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-39.27%
|
O:
0.78%
H:
0.39%
C:
-2.39%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.95%
|
O:
-0.32%
H:
0.18%
C:
-0.44%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
11.74%
|
O:
-0.51%
H:
0.24%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-14.18%
|
O:
0.36%
H:
0.0%
C:
0.0%
treatment
growth
market
Oncology Drugs Market to grow at a CAGR of 11.99% from 2022 to 2027. AbbVie Inc., Amgen Inc. & Apikos Pharma are major vendors - Technavio
Published:
2023-07-27
(Crawled : 05:00)
- prnewswire.com
ABBNY
|
News
|
$45.795
4.05%
170K
|
n/a
|
14.04%
|
O:
2.13%
H:
0.04%
C:
-1.67%
ABLZF
|
News
|
$45.744
-32.74%
1.5K
|
Producer Manufacturing
|
10.6%
|
O:
0.58%
H:
0.0%
C:
-0.46%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
12.04%
|
O:
2.38%
H:
2.49%
C:
2.49%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-37.4%
|
O:
3.75%
H:
0.0%
C:
-2.78%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-10.41%
|
O:
0.7%
H:
0.12%
C:
-0.76%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
10.4%
|
O:
1.03%
H:
0.39%
C:
-1.02%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
16.75%
|
O:
2.13%
H:
4.77%
C:
3.02%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-14.23%
|
O:
0.92%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
12.64%
|
O:
-0.31%
H:
1.71%
C:
0.67%
pharma
abbvie
market
Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published:
2023-07-14
(Crawled : 11:00)
- prnewswire.com
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-3.37%
|
O:
-0.54%
H:
0.0%
C:
-1.4%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
14.45%
|
O:
0.0%
H:
1.42%
C:
0.96%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
1.28%
|
O:
6.03%
H:
-2.14%
C:
-2.14%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-35.63%
|
O:
0.96%
H:
0.0%
C:
-1.71%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
13.79%
|
O:
0.03%
H:
0.2%
C:
-0.8%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-1.24%
|
O:
0.24%
H:
0.44%
C:
-0.06%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-13.35%
|
O:
0.36%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
0.82%
|
O:
1.79%
H:
0.0%
C:
-2.23%
pharma
vaccine
research
market
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published:
2023-06-28
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
17.51%
|
O:
1.75%
H:
0.06%
C:
0.06%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-3.63%
|
O:
1.06%
H:
0.72%
C:
0.72%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-38.43%
|
O:
-1.98%
H:
0.0%
C:
-0.47%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.44%
|
O:
0.17%
H:
0.85%
C:
0.76%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
11.46%
|
O:
-1.21%
H:
1.17%
C:
0.91%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-1.12%
|
O:
-0.54%
H:
0.78%
C:
0.59%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-15.68%
|
O:
-1.86%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-3.8%
|
O:
-0.83%
H:
0.89%
C:
0.68%
lung
disease
report
treatment
global
growth
market
Orphan drugs market to grow by USD 170.8 billion between 2022 and 2027; Growth driven by rising incidence of rare diseases - Technavio
Published:
2023-05-03
(Crawled : 01:00)
- prnewswire.com
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-12.47%
|
O:
-0.56%
H:
0.36%
C:
-0.28%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-7.42%
|
O:
3.52%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
10.16%
|
O:
-1.96%
H:
0.0%
C:
0.0%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-38.02%
|
O:
1.86%
H:
0.0%
C:
-0.65%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-10.1%
|
O:
0.55%
H:
0.68%
C:
0.33%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
8.94%
|
O:
1.24%
H:
1.14%
C:
0.11%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
8.93%
|
O:
-0.36%
H:
0.29%
C:
-1.2%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-14.78%
|
O:
0.71%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-7.37%
|
O:
0.75%
H:
0.98%
C:
0.46%
rare
growth
market
Global Penicillin Market Report 2023: Rising Prevalence of Various Types of Infections Drives Growth
Published:
2023-04-14
(Crawled : 19:00)
- prnewswire.com
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
Email alert
Add to watchlist
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
report
global
infections
growth
market
Acne Drugs Market size to grow by USD 907.11 million from 2022 to 2027, Driven by the emergence of improved diagnostic modalities - Technavio
Published:
2023-04-14
(Crawled : 04:00)
- prnewswire.com
DERM
|
$3.54
-8.29%
-9.04%
190K
|
|
131.71%
|
O:
-8.54%
H:
2.0%
C:
0.0%
RBGPF
|
$52.0
6.46%
34K
|
Consumer Non-Durables
|
-34.41%
|
O:
-1.42%
H:
0.0%
C:
-0.22%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
8.31%
|
O:
0.94%
H:
0.0%
C:
-0.93%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-36.07%
|
O:
1.98%
H:
0.0%
C:
-0.6%
RBGLY
|
$10.29
-2.05%
1.4M
|
Manufacturing
|
-35.34%
|
O:
-0.35%
H:
0.33%
C:
0.13%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
12.1%
|
O:
-0.2%
H:
0.51%
C:
-0.3%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
3.34%
|
O:
-0.57%
H:
0.04%
C:
-0.87%
XBIT
|
$7.9
-2.59%
-2.66%
99K
|
Health Technology
|
124.03%
|
O:
-0.83%
H:
1.95%
C:
-0.84%
diagnostic
acne
market
← Previous
1
2
3
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.